Network origin in Brian Greenwood first degree
Entity | Entity type | Industry | |
---|---|---|---|
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson.
15
| Non-Profit Organization | Medical/Nursing Services | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brian Greenwood via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Basel | College/University | Undergraduate Degree Corporate Officer/Principal | |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
The Hebrew University of Jerusalem | College/University | Graduate Degree | |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
University of London | College/University | Graduate Degree | |
Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | Hospital/Nursing Management | Director/Board Member | |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Director/Board Member | |
RELIEF THERAPEUTICS HOLDING SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Mumbai | College/University | Doctorate Degree | |
University of Oxford | College/University | Doctorate Degree | |
INSEAD | College/University | Masters Business Admin | |
Baobab Circle Ltd.
Baobab Circle Ltd. Packaged SoftwareTechnology Services Baobab Circle Ltd. develops artificial intelligence based mobile application to manage diabetes and hypertension. It offers Afya Pap has a wide range of useful functionality to help users to tackle their condition. The company was founded by Precious Lunga and George Franklin on May 31, 2013 and is headquartered in London, the United Kingdom. | Packaged Software | Founder |
Statistics
International
Switzerland | 7 |
United Kingdom | 5 |
South Korea | 2 |
Israel | 2 |
India | 2 |
Sectoral
Consumer Services | 8 |
Health Technology | 4 |
Health Services | 3 |
Commercial Services | 2 |
Technology Services | 2 |
Operational
Director/Board Member | 18 |
Chairman | 3 |
Doctorate Degree | 3 |
Undergraduate Degree | 2 |
Graduate Degree | 2 |
Most connected contacts
- Stock Market
- Insiders
- Brian Greenwood
- Company connections